Revenue YoY
+13.81%
Operating Income YoY
+22.25%
Net Income YoY
-73.80%
Net Margin Δ
-5813 bps
Net income bridge for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: -$3.09B-73.80%
Profit bridge breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $4.18B | — |
| Revenue | $765M | +24.8% |
| Cost of Revenue | -$233M | -7.6% |
| Operating Expenses | -$215M | -7.0% |
| Other Income / Expense | -$634M | -20.5% |
| Income Tax | -$48.6M | -1.6% |
| Other Items | -$2.72B | -88.1% |
| Net Income | $1.09B | — |
- Prior Net Income$4.18B
- Revenue$765M
- Cost of Revenue-$233M
- Operating Expenses-$215M
- Other Income / Expense-$634M
- Income Tax-$48.6M
- Other Items-$2.72B
- Net Income$1.09B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.